Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Interactive:
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Quiz
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Exams
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Psychiatry


Answer 2
  1. Approximately every 3 months. The American Psychiatric Association recommends that patients receiving antipsychotic medication be evaluated approximately every 3 months for signs of tardive dyskinesia.2 The risk of tardive dyskinesia is significantly less but not completely eliminated, with atypical antipsychotic agents.1,3 Symptoms of tardive dyskinesia may not resolve when the antipsychotic agent is stopped.2 All patients should be monitored regardless of whether there is a prior history of tardive dyskinesia.

    REFERENCES
    1. Sadock BJ, Sadock VA. Biological therapies. In: Synopsis of psychiatry. Philadelphia: Lippincott, Williams & Wilkins; 2003:505-1150.
    2. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. 2nd ed. American Psychiatric Association practice guidelines for the treatment of psychiatric disorders compendium 2002. Washington (DC): The Association; 2002:349-461.
    3. Kane JM. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J Clin Psychiatry 2004;65(Suppl 9):16-20.

Click here to return to the questions

 

Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 4/6/07 • kkj